Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

SUPNSUPN
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in SUPERNUS PHARMACEUTICALS

BANK OF AMERICA CORP /DE/ holds 714,226 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $36.9M as of 2026-Q1. The position was increased (+37.1% shares). SUPN represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$36.9M

Current Shares

714,226

Total Value Change

+$23.4M

Total Shares Change

+341,138

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
714,226
+37.1%
$36.9M0.0%$54.56
38
2025-Q4
Decreased
520,747
-38.2%
$25.9M0.0%$49.89
0
2025-Q3
Increased
842,890
+67.1%
$40.3M0.0%$47.60
43
2025-Q2
Increased
504,306
+4.4%
$15.9M0.0%$31.16
29
2025-Q1
Increased
483,079
+29.5%
$15.8M0.0%$32.29
35
2024-Q4
New
373,088
-
$13.5M0.0%$36.91
39

Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used